THE FAUCI FILE

Here is a chronological and thematically structured overview integrating Dr. Anthony Fauci’s role and connections regarding:

• Gain-of-Function research (GoF)

• mRNA vaccine development

• Relations with the Trump and Biden administrations

• COVID-19 strategy

Before the Pandemic (2011–2019): Preparation, GoF, and Vaccine Platforms

2011–2017: GoF and Pandemic Research

• As director of NIAID (1984–2022), Fauci supported funding of research on zoonotic viruses, including Gain-of-Function.

• In 2012, he defended GoF research in the article “Research on Highly Pathogenic H5N1 Influenza Virus: The Way Forward”, arguing it could be justified to prepare for pandemics.

• Through NIH/NIAID, he funded EcoHealth Alliance, which in turn funded the Wuhan Institute of Virology (WIV) for bat coronavirus research.

• In 2014, the Obama administration paused GoF research, but exemptions were granted by NIH/NIAID for ongoing projects.

2013–2019: mRNA as the Vaccine Platform of the Future

• NIAID initiated collaborations with Moderna starting in 2013 to develop mRNA-based vaccines against MERS, Zika, and influenza.

• By 2017, Fauci became a strong advocate for using mRNA as a pandemic platform: “If you want to get a vaccine quickly, the mRNA platform is the best hope.”

Start of the Pandemic – The Trump Era (2020)

Jan–Mar 2020: Uncertainty and Initial Cooperation

• Fauci initially downplayed the risk: “Risk to Americans is low” (January).

• Meanwhile, he worked behind the scenes to protect research networks: he joined meetings in February 2020 with scientists (e.g., Kristian Andersen) where GoF and a possible lab origin of the virus were discussed.

• He contributed to the editing of “The proximal origin of SARS-CoV-2”, an article that strongly dismissed the lab-leak theory—despite private emails indicating he was not convinced.

Mar 2020–Jan 2021: Tensions with Trump

• Fauci became a public science figure—praised by the media but frequently clashing with Trump.

• He defended lockdowns and masks, while Trump pushed for reopening.

• At the same time, he directed NIAID’s collaboration with Moderna, which was chosen to rapidly develop an mRNA vaccine using a pre-designed “vaccine plug” for SARS-CoV-2.

• NIAID co-patented key elements of the mRNA vaccine platform alongside Moderna.

The Biden Era (2021–2022): Scientific Influence and Defense

Jan 2021: Fauci Takes on a New Role

• Biden appointed Fauci as his chief medical advisor, giving him significant influence over the pandemic strategy.

• Fauci described it as “liberating” to be able to speak without being “contradicted.”

2021–2022: Centralizing the mRNA Strategy

• Fauci defended mass vaccination with mRNA vaccines, even for children and those previously infected.

• He promoted booster doses, despite criticism from some immunologists and epidemiologists.

• He continued to downplay the possibility of a lab origin for SARS-CoV-2, despite a growing debate.

• NIAID’s ties to Moderna and the mRNA platform deepened—both financially and politically.

Legacy and New Conflicts (2023–2025)

2023: Criticism, Investigations, and NIH Defense

• Congressional investigations and journalistic reports (e.g., The Intercept, Vanity Fair) revealed a lack of transparency in GoF funding.

• Fauci’s earlier role in shaping the narrative away from a possible lab origin came under intense scrutiny.

2024–2025: Political Confrontation and Protection

• Biden issued a preemptive pardon for Fauci in January 2025, shielding him from potential prosecution over pandemic management.

• Trump’s return to office in January 2025 marked a new phase: Fauci’s security detail was removed, and he became a target for political retribution.

• In April 2025, the new Trump administration launched an official COVID website criticizing Fauci, the WHO, and vaccine companies—highlighting the lab-leak theory.